Rockefeller Capital Management
INAB icon

Rockefeller Capital Management’s IN8bio INAB Stock Holding History

Rockefeller Capital Management’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$123 Hold
83
– – ﹤0.01% 4627
2025
Q4 		$194 Hold
83
– – ﹤0.01% 4593
2025
Q3 		$180 Buy
+83
New +$183 ﹤0.01% 4352

Other funds holding INAB

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Rockefeller Capital Management's INAB Position: Q1 2026 in Review

Rockefeller Capital Management held its IN8bio (INAB) position steady in Q1 2026 at 83 shares worth $123. The position accounts for ﹤0.01% of the portfolio, ranked #4627.

Rockefeller Capital Management first reported a position in INAB in Q3 2025 and has held it in 3 quarters since. The position peaked at $194 in Q4 2025. 19 funds tracked by Wall St. Rank hold INAB as of Q1 2026.

  • Rockefeller Capital Management held 83 shares of IN8bio worth $123 as of Q1 2026.
  • Rockefeller Capital Management left its IN8bio share count unchanged in Q1 2026.
  • IN8bio made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4627 holding.
  • Rockefeller Capital Management first reported a position in IN8bio in Q3 2025 and has held it in 3 quarters since.
  • Rockefeller Capital Management's IN8bio position peaked at $194 in Q4 2025.
  • 19 funds tracked by Wall St. Rank held IN8bio as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.